Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Glioma | 9 | 2018 | 189 | 3.16 | Why? |
| Brain Neoplasms | 12 | 2018 | 669 | 2.75 | Why? |
| Glioblastoma | 5 | 2018 | 187 | 1.83 | Why? |
| Neural Crest | 2 | 2017 | 9 | 1.16 | Why? |
| Magnetic Resonance Imaging | 9 | 2020 | 6551 | 1.06 | Why? |
| Chromatin | 3 | 2018 | 107 | 0.99 | Why? |
| Neuroimaging | 6 | 2020 | 1106 | 0.95 | Why? |
| Gene Expression Regulation, Developmental | 3 | 2018 | 159 | 0.87 | Why? |
| Leukoencephalopathies | 2 | 2020 | 230 | 0.85 | Why? |
| Nuclear Lamina | 1 | 2017 | 2 | 0.73 | Why? |
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 10 | 0.72 | Why? |
| Polycomb Repressive Complex 2 | 1 | 2017 | 10 | 0.71 | Why? |
| Chromosomes, Human, Pair 1 | 1 | 2017 | 11 | 0.71 | Why? |
| Cerebral Hemorrhage | 3 | 2020 | 820 | 0.71 | Why? |
| Chromosomes, Human, Pair 19 | 1 | 2017 | 77 | 0.71 | Why? |
| Histone Deacetylases | 1 | 2017 | 37 | 0.70 | Why? |
| Chromosome Aberrations | 1 | 2017 | 54 | 0.68 | Why? |
| Myocardium | 3 | 2018 | 2323 | 0.68 | Why? |
| Stem Cells | 3 | 2018 | 595 | 0.68 | Why? |
| Sodium | 1 | 2018 | 309 | 0.61 | Why? |
| Mammals | 1 | 2018 | 315 | 0.61 | Why? |
| Arteries | 1 | 2017 | 283 | 0.57 | Why? |
| Histones | 1 | 2017 | 371 | 0.55 | Why? |
| Positron-Emission Tomography | 1 | 2017 | 802 | 0.47 | Why? |
| Heart | 2 | 2018 | 1791 | 0.44 | Why? |
| Endothelial Cells | 3 | 2017 | 2048 | 0.42 | Why? |
| Chemoradiotherapy | 1 | 2013 | 362 | 0.42 | Why? |
| Mesoderm | 3 | 2017 | 15 | 0.40 | Why? |
| Stroke | 3 | 2020 | 8839 | 0.36 | Why? |
| White Matter | 2 | 2021 | 369 | 0.33 | Why? |
| Neoplasm Grading | 2 | 2018 | 400 | 0.32 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.28 | Why? |
| Regeneration | 2 | 2018 | 429 | 0.27 | Why? |
| Aortic Valve | 1 | 2010 | 664 | 0.27 | Why? |
| Diffusion Magnetic Resonance Imaging | 2 | 2018 | 317 | 0.26 | Why? |
| Transcription Factors | 3 | 2018 | 784 | 0.25 | Why? |
| Angiogenesis Inhibitors | 2 | 2017 | 395 | 0.25 | Why? |
| Image Interpretation, Computer-Assisted | 3 | 2018 | 665 | 0.22 | Why? |
| Brain | 6 | 2021 | 5133 | 0.21 | Why? |
| Atrophy | 1 | 2020 | 192 | 0.21 | Why? |
| Cell Lineage | 2 | 2018 | 241 | 0.20 | Why? |
| Tumor Suppressor Proteins | 2 | 2018 | 165 | 0.20 | Why? |
| Tyrosinemias | 1 | 2018 | 1 | 0.20 | Why? |
| Ceruloplasmin | 1 | 2018 | 12 | 0.19 | Why? |
| Ferrosoferric Oxide | 1 | 2018 | 19 | 0.19 | Why? |
| Putamen | 1 | 2018 | 24 | 0.18 | Why? |
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2017 | 1 | 0.18 | Why? |
| Iron Metabolism Disorders | 1 | 2018 | 24 | 0.18 | Why? |
| Enteroendocrine Cells | 1 | 2017 | 5 | 0.18 | Why? |
| Optic Nerve Glioma | 1 | 2017 | 3 | 0.18 | Why? |
| Tumor Hypoxia | 1 | 2017 | 9 | 0.18 | Why? |
| Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 6 | 0.17 | Why? |
| Nuclear Pore Complex Proteins | 1 | 2018 | 53 | 0.17 | Why? |
| Oxidoreductases | 1 | 2018 | 136 | 0.17 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 40 | 0.17 | Why? |
| Jejunum | 1 | 2017 | 82 | 0.17 | Why? |
| Proprotein Convertase 9 | 1 | 2018 | 141 | 0.17 | Why? |
| Embryo, Mammalian | 1 | 2017 | 86 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2017 | 93 | 0.17 | Why? |
| Cell Cycle | 1 | 2018 | 329 | 0.16 | Why? |
| Hematopoiesis | 1 | 2017 | 168 | 0.16 | Why? |
| Neovascularization, Pathologic | 2 | 2017 | 305 | 0.16 | Why? |
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 502 | 0.16 | Why? |
| Methylation | 1 | 2017 | 332 | 0.16 | Why? |
| Mice | 7 | 2018 | 21357 | 0.15 | Why? |
| Antigens, Differentiation | 1 | 2017 | 172 | 0.15 | Why? |
| Human Embryonic Stem Cells | 1 | 2017 | 199 | 0.15 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.15 | Why? |
| Intracranial Thrombosis | 1 | 2020 | 339 | 0.15 | Why? |
| Gene Deletion | 1 | 2017 | 430 | 0.15 | Why? |
| Blood Vessels | 1 | 2017 | 228 | 0.15 | Why? |
| Genome | 1 | 2017 | 341 | 0.14 | Why? |
| Anticoagulants | 3 | 2020 | 9563 | 0.14 | Why? |
| Hospitals, Urban | 1 | 2020 | 950 | 0.14 | Why? |
| Piperazines | 1 | 2017 | 445 | 0.14 | Why? |
| Pericardium | 1 | 2017 | 228 | 0.14 | Why? |
| Myocytes, Cardiac | 2 | 2017 | 804 | 0.13 | Why? |
| Animals | 11 | 2018 | 78931 | 0.13 | Why? |
| Blood-Brain Barrier | 1 | 2018 | 531 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.13 | Why? |
| Dacarbazine | 1 | 2013 | 67 | 0.13 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.13 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.12 | Why? |
| Radiometry | 1 | 2013 | 136 | 0.12 | Why? |
| New York City | 3 | 2020 | 7432 | 0.12 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.11 | Why? |
| Endocardial Cushion Defects | 1 | 2010 | 1 | 0.11 | Why? |
| PAX3 Transcription Factor | 1 | 2010 | 2 | 0.11 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.11 | Why? |
| Neurodegenerative Diseases | 1 | 2018 | 469 | 0.11 | Why? |
| Paired Box Transcription Factors | 1 | 2010 | 4 | 0.11 | Why? |
| Diagnostic Errors | 1 | 2018 | 865 | 0.11 | Why? |
| Female | 21 | 2020 | 380317 | 0.11 | Why? |
| Mice, Mutant Strains | 1 | 2010 | 42 | 0.11 | Why? |
| Male | 18 | 2020 | 367725 | 0.11 | Why? |
| Intracranial Hemorrhages | 1 | 2020 | 1170 | 0.11 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.11 | Why? |
| Receptors, Notch | 1 | 2010 | 59 | 0.11 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.11 | Why? |
| Metal Nanoparticles | 1 | 2018 | 771 | 0.11 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2017 | 698 | 0.10 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.10 | Why? |
| Adult | 12 | 2020 | 244371 | 0.10 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.10 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.10 | Why? |
| Models, Cardiovascular | 1 | 2010 | 153 | 0.10 | Why? |
| Phosphoproteins | 2 | 2018 | 4346 | 0.10 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.10 | Why? |
| Isocitrate Dehydrogenase | 2 | 2018 | 33 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.09 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Middle Aged | 13 | 2020 | 270681 | 0.09 | Why? |
| Thrombosis | 2 | 2020 | 7504 | 0.09 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.09 | Why? |
| Aged, 80 and over | 6 | 2020 | 88759 | 0.09 | Why? |
| Aged | 11 | 2020 | 215776 | 0.09 | Why? |
| Acyltransferases | 2 | 2018 | 61 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.09 | Why? |
| Radiotherapy | 1 | 2013 | 608 | 0.08 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.08 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.08 | Why? |
| Respiration, Artificial | 3 | 2020 | 22116 | 0.08 | Why? |
| Prognosis | 3 | 2020 | 32490 | 0.08 | Why? |
| Infant | 2 | 2020 | 30274 | 0.08 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.08 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.08 | Why? |
| Cell Cycle Proteins | 2 | 2018 | 297 | 0.07 | Why? |
| Venous Thrombosis | 1 | 2020 | 2739 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Neoplasm Invasiveness | 2 | 2017 | 582 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.06 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Tertiary Care Centers | 1 | 2020 | 8248 | 0.06 | Why? |
| Machine Learning | 1 | 2018 | 4395 | 0.06 | Why? |
| Treatment Outcome | 4 | 2020 | 51732 | 0.05 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.05 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.05 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.05 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.05 | Why? |
| Apoptosis | 1 | 2010 | 2335 | 0.05 | Why? |
| Child | 2 | 2020 | 70012 | 0.05 | Why? |
| Mice, Transgenic | 2 | 2017 | 2739 | 0.05 | Why? |
| Spinal Cord | 1 | 2021 | 281 | 0.05 | Why? |
| Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
| Neuregulin-1 | 1 | 2018 | 8 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| DNA Modification Methylases | 1 | 2018 | 11 | 0.05 | Why? |
| Organogenesis | 1 | 2018 | 24 | 0.05 | Why? |
| CRISPR-Cas Systems | 2 | 2018 | 1397 | 0.05 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.05 | Why? |
| DNA Repair Enzymes | 1 | 2018 | 33 | 0.05 | Why? |
| International Normalized Ratio | 1 | 2020 | 300 | 0.05 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
| Acrylamides | 1 | 2017 | 40 | 0.04 | Why? |
| Gastrulation | 1 | 2017 | 1 | 0.04 | Why? |
| Endocardium | 1 | 2018 | 90 | 0.04 | Why? |
| Mouse Embryonic Stem Cells | 1 | 2017 | 17 | 0.04 | Why? |
| Aniline Compounds | 1 | 2017 | 120 | 0.04 | Why? |
| Embryonic Development | 1 | 2017 | 55 | 0.04 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.04 | Why? |
| Antineoplastic Agents | 1 | 2013 | 3550 | 0.04 | Why? |
| Cell Hypoxia | 1 | 2017 | 141 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
| Neoplastic Stem Cells | 1 | 2017 | 120 | 0.04 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.04 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.04 | Why? |
| Genes, Reporter | 1 | 2017 | 472 | 0.04 | Why? |
| Bevacizumab | 1 | 2017 | 149 | 0.04 | Why? |
| Pluripotent Stem Cells | 1 | 2017 | 167 | 0.04 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 243 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Gene Editing | 1 | 2018 | 330 | 0.04 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.04 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
| Molecular Imaging | 1 | 2015 | 110 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Heart Atria | 1 | 2017 | 267 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Disease Progression | 1 | 2013 | 13580 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Endothelium | 1 | 2017 | 460 | 0.03 | Why? |
| Endpoint Determination | 1 | 2015 | 344 | 0.03 | Why? |
| Patient Care Planning | 1 | 2018 | 582 | 0.03 | Why? |
| Fluorescent Dyes | 1 | 2017 | 536 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.03 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2017 | 881 | 0.03 | Why? |
| Genetic Vectors | 1 | 2018 | 1600 | 0.03 | Why? |
| Multimodal Imaging | 1 | 2015 | 534 | 0.03 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.02 | Why? |
| Algorithms | 2 | 2017 | 7346 | 0.02 | Why? |
| Pregnancy | 1 | 2010 | 23879 | 0.02 | Why? |
| Radiography | 1 | 2015 | 1576 | 0.02 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.02 | Why? |
| Cluster Analysis | 1 | 2015 | 3001 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.02 | Why? |
| Phenotype | 1 | 2015 | 4037 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| African Americans | 1 | 2018 | 3363 | 0.02 | Why? |
| MicroRNAs | 1 | 2015 | 1787 | 0.01 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Survival Analysis | 1 | 2015 | 7592 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2015 | 9537 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
Jain's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_